Trial of Precision Medicine in Emergency Departments
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- University of Florida
- Study ID
- NCT06448091
- Status
- Recruiting
Conditions
- Pharmacogenomic Drug Interaction
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Panel-based pharmacogenetic genotyping — DIAGNOSTIC_TESTAfter consent and randomization into the immediate PGx testing, participants' results will (10-14 days after randomization) go into their EHR and be returned via a laminated results card
Study Details
The objectives of this study are to (1) test the feasibility of the clinical implementation of preemptive pharmacogenetic (PGx) testing in the emergency department (ED) and (2) determine if PGx testing (with appropriate decision support) decreases ED return visits and hospitalizations. We will conduct a randomized, controlled, pragmatic clinical trial assessing both the real-world effectiveness as well as implementation outcomes using a targeted PGx testing panel in several UF Health EDs.
Key Dates
- Start date
- Mar 18, 2025
- Status verified
- Jun 2026
- Primary completion
- Feb 1, 2029
- Completion
- Feb 1, 2029
Study Design
- Enrollment
- 1,200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Experimental: Immediate panel-based pharmacogenetic genotypingSubjects assigned to the immediate pharmacogenetic genotyping group will be tested and have their results both entered into their electronic health record as well as provided to them within 2-4 weeks from randomization.
- No Intervention: Delayed panel-based pharmacogenetic genotypingSubjects assigned to delayed panel-based pharmacogenetic genotyping will not be tested until after their participation in the study has ended (6 months after enrollment).
Primary Outcome Measure
ED recidivism [ Time Frame: Baseline to 6 months ]
Central Contacts
- Erica N Elwood, MHA3522736007
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UF Health Emergency Department | Gainesville | Florida | 32610 | |
| UF Health Jacksonville Downtown Emergency Department | Jacksonville | Florida | 32209 | Sophia Sheikh, MD (PRINCIPAL_INVESTIGATOR) |
| UF Health Jacksonville North Emergency Department | Jacksonville | Florida | 32218 | Sophia Sheikh, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Gainesville, FL
Related Studies
- The Geriatric Emergency Department Pharmacologic Harm Prevention ProjectRecruiting · Florida Atlantic University · Delray Beach, Florida
- Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:PHASE2 · Recruiting · Mayo Clinic · Rochester, Minnesota
- Oral Contraceptive Pill (OCP) PharmacogenomicsPHASE4 · Recruiting · Yale University · Aurora, Colorado
- Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral PalsyPHASE1 · Recruiting · Children's Mercy Hospital Kansas City · Kansas City, Missouri